VGI Medical announced the successful completion of initial surgeries using its proprietary SiJoin T4 implant. Full launch is slated for 1Q25.
Dr. Jeff Beck, performing surgeon, said, “The T4, a porous, 3D-printed titanium device, is designed with extensive bone graft windows and vertical spiked fins which provide superior fixation and stability, promoting accelerated bone ingrowth across its osteoconductive surface. Unlike structural allografts, which may resorb and weaken over time, the T4 implant retains its mechanical integrity, leading to a more predictable, durable fusion.”
Tov Vestgaarden, VGI Medical’s President, CEO and founder, said, “These surgeries mark the beginning of our next phase toward full commercialization. As we prepare for a comprehensive product launch, our focus is on building inventory of disposable instruments and finalizing our kits, with the goal of achieving a full rollout by Q1 2025.”
VGI Medical announced the successful completion of initial surgeries using its proprietary SiJoin T4 implant. Full launch is slated for 1Q25.
Dr. Jeff Beck, performing surgeon, said, “The T4, a porous, 3D-printed titanium device, is designed with extensive bone graft windows and vertical spiked fins which provide superior fixation and...
VGI Medical announced the successful completion of initial surgeries using its proprietary SiJoin T4 implant. Full launch is slated for 1Q25.
Dr. Jeff Beck, performing surgeon, said, “The T4, a porous, 3D-printed titanium device, is designed with extensive bone graft windows and vertical spiked fins which provide superior fixation and stability, promoting accelerated bone ingrowth across its osteoconductive surface. Unlike structural allografts, which may resorb and weaken over time, the T4 implant retains its mechanical integrity, leading to a more predictable, durable fusion.”
Tov Vestgaarden, VGI Medical’s President, CEO and founder, said, “These surgeries mark the beginning of our next phase toward full commercialization. As we prepare for a comprehensive product launch, our focus is on building inventory of disposable instruments and finalizing our kits, with the goal of achieving a full rollout by Q1 2025.”
Copy to clipboard 
